论文部分内容阅读
血脂,特别是低密度脂蛋白胆固醇(LDL-C)是冠状动脉粥样硬化性心脏病的危险因素,在心内科,医生对血脂,特别是对LDL-C的重视正在逐步提升。缺血性脑卒中重要的病因之一是脑动脉(包括大脑前中后动脉、颈动脉等)的粥样硬化。在冠状动脉粥样硬化中起到关键性作用的LDL-C是否同样是脑卒中的重要危险因素呢?心内科正在开展胆固醇教育计划,积极倡导降脂治疗,脑卒中患者化验单血脂在正常范围内,是否还需要降脂治疗呢?使用他汀类降脂药物降低血清胆固醇后,会不会带来脑出血的增加呢?他汀类降脂药物是否仅仅通过降低血脂这一条途径达到降低脑卒中的风险呢?就上述话题,我们约请了北京天坛医院王拥军教授和北京解放军总医院叶平教授开展了心脑对话——血脂篇,内容将分两期刊登。
Blood lipids, especially low-density lipoprotein cholesterol (LDL-C), are risk factors for coronary atherosclerotic heart disease. In cardiology, physicians are gradually increasing their emphasis on blood lipids, especially LDL-C. One of the important causes of ischemic stroke is atherosclerosis of the cerebral arteries, including the anterior and middle cerebral arteries, carotid arteries and the like. Is LDL-C, which plays a pivotal role in coronary atherosclerosis, also an important risk factor for stroke? Cardiology is conducting a cholesterol education program that actively promotes lipid-lowering therapy. Stroke patients are tested for mono-lipids in the normal range Is there any need for lipid-lowering therapy? Will statin-lowering drugs lower serum cholesterol after cerebral hemorrhage? Does statin lipid-lowering drugs reduce stroke by mere lipid lowering? Risk? On the above topic, we invited Professor Wang Yongjun from Beijing Tiantan Hospital and Beijing General Hospital of PLA General Hospital Ye Ping conducted a heart-brain dialogue - blood lipids, the content will be published in two phases.